Page last updated: 2024-10-15

3-hydroxykynurenine and Attention Deficit Disorder with Hyperactivity

3-hydroxykynurenine has been researched along with Attention Deficit Disorder with Hyperactivity in 1 studies

3-hydroxykynurenine: RN given refers to cpd without isomeric designation
3-hydroxykynurenine : A hydroxykynurenine that is kynurenine substituted by a hydroxy group at position 3.
hydroxykynurenine : A hydroxy-amino acid that is kynurenine substituted by a single hydroxy group at unspecified position. A "closed" class.

Attention Deficit Disorder with Hyperactivity: A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-V)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Oades, RD1
Dauvermann, MR1
Schimmelmann, BG1
Schwarz, MJ1
Myint, AM1

Other Studies

1 other study available for 3-hydroxykynurenine and Attention Deficit Disorder with Hyperactivity

ArticleYear
Attention-deficit hyperactivity disorder (ADHD) and glial integrity: S100B, cytokines and kynurenine metabolism--effects of medication.
    Behavioral and brain functions : BBF, 2010, May-28, Volume: 6

    Topics: Adolescent; Amino Acids; Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous Syste

2010